Clinical Trial Update: Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing intramuscular ketamine to aripiprazole and escitalopram for treatment-resistant depression is ongoing, with status currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)
• Escitalopram (escitalopram)
• ketamine (intramuscular) (ketamine)

Snippet

Sponsor: University of Sao Paulo | Conditions: Depressive Disorder | Phase 4 | Status: UNKNOWN